We are live on ! Find out more
BCM

Blume Capital Management Portfolio holdings

AUM $684M
1-Year Est. Return 41.68%
This Fund
S&P 500
This Quarter Est. Return
-15.95%
1 Year Est. Return
+41.68%
3 Year Est. Return
+96.87%
5 Year Est. Return
+108.87%
10 Year Est. Return
+366.52%
AUM
$253M
AUM Growth
-$50M
Cap. Flow
-$666K
Cap. Flow %
-0.26%
Top 10 Hldgs %
38.86%
Holding
351
New
30
Increased
68
Reduced
60
Closed
30

Top Sells

Rank Stock Value
1
VCSH icon
Vanguard Short-Term Corporate Bond ETF
VCSH
+$7.91M
2
TMUS icon
T-Mobile US
TMUS
+$3.28M
3
CVS icon
CVS Health
CVS
+$3.12M
4
WY icon
Weyerhaeuser
WY
+$3.1M
5
VZ icon
Verizon
VZ
+$3.07M

Sector Composition

Rank Sector Weight
1 Technology 22.39%
2 Financials 17.7%
3 Communication Services 14.79%
4 Industrials 6.41%
5 Healthcare 5.81%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AAPL icon
1
Apple
AAPL
$4.54T
$13.6M 5.36%
99,291
-5,534
-5% -$838K
XLE icon
2
State Street Energy Select Sector SPDR ETF
XLE
$39.6B
$13.2M 5.21%
369,010
-4,650
-1% -$187K
FDX icon
3
FedEx
FDX
$72.7B
$12M 4.72%
52,750
+3,847
+8% +$821K
GOOG icon
4
Alphabet (Google) Class C
GOOG
$4.36T
$10.1M 3.99%
92,320
+2,540
+3% +$300K
SCHW
5
Charles Schwab
SCHW
$183B
$9.54M 3.77%
150,939
+28,125
+23% +$1.94M
CMCSA icon
6
Comcast
CMCSA
$85B
$8.9M 3.52%
226,820
+6,701
+3% +$287K
VCSH icon
7
Vanguard Short-Term Corporate Bond ETF
VCSH
$44.7B
$8.06M 3.18%
105,647
-102,949
-49% -$7.91M
JNJ icon
8
Johnson & Johnson
JNJ
$618B
$7.99M 3.16%
45,022
-10,994
-20% -$1.96M
IBB icon
9
iShares Biotechnology ETF
IBB
$9.34B
$7.67M 3.03%
65,228
+4,320
+7% +$513K
DIS icon
10
Walt Disney
DIS
$167B
$7.4M 2.92%
78,422
+15,690
+25% +$1.74M
MSFT icon
11
Microsoft
MSFT
$3.45T
$7.11M 2.81%
27,695
+206
+0.7% +$55.9K
C icon
12
Citigroup
C
$222B
$6.63M 2.62%
144,204
+4,625
+3% +$231K
TMUS icon
13
T-Mobile US
TMUS
$185B
$6.54M 2.58%
48,598
-25,157
-34% -$3.28M
MU icon
14
Micron Technology
MU
$930B
$6.14M 2.43%
111,067
+30,665
+38% +$2.08M
COF icon
15
Capital One
COF
$128B
$6.01M 2.37%
57,679
+4,671
+9% +$571K
QCOM icon
16
Qualcomm
QCOM
$155B
$5.66M 2.24%
44,330
+11,169
+34% +$1.52M
AMAT icon
17
Applied Materials
AMAT
$403B
$5.45M 2.15%
59,916
+18,893
+46% +$2.07M
WY icon
18
Weyerhaeuser
WY
$18B
$5.36M 2.12%
161,845
-81,346
-33% -$3.1M
WFC icon
19
Wells Fargo
WFC
$261B
$5.32M 2.1%
135,874
+3,118
+2% +$137K
BKR icon
20
Baker Hughes
BKR
$60B
$5.04M 1.99%
174,690
+1,925
+1% +$65.1K
INTC icon
21
Intel
INTC
$455B
$4.42M 1.75%
118,167
+2,860
+2% +$124K
BAC icon
22
Bank of America
BAC
$435B
$4.4M 1.74%
141,416
+80,625
+133% +$2.9M
GS icon
23
Goldman Sachs
GS
$300B
$4.32M 1.71%
14,538
+577
+4% +$180K
FISV
24
Fiserv Inc
FISV
$28.8B
$4.28M 1.69%
48,145
+19,715
+69% +$1.91M
CVS icon
25
CVS Health
CVS
$133B
$4.16M 1.64%
44,916
-31,955
-42% -$3.12M

Similar funds

Blume Capital Management's Q2 2022 Portfolio in Review

As of Q2 2022, Blume Capital Management held 351 positions worth $253M, down 17% from $303M the previous quarter. Its ten largest holdings account for 39% of the portfolio.

Blume Capital Management's Q2 2022 filing shows 30 new, 68 increased, 60 reduced and 30 closed positions. Its largest new stake was Alcoa: 31,695 shares worth $1.45M. The largest sale was Vanguard Short-Term Corporate Bond ETF, an estimated $7.91M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 21% a quarter earlier, followed by Financials and Communication Services.

  • Blume Capital Management's largest Q2 2022 buy was Alcoa: 31,695 shares worth $1.45M.
  • Blume Capital Management added most to Bank of America in Q2 2022, an estimated $2.9M increase.
  • Blume Capital Management's biggest Q2 2022 reduction was Vanguard Short-Term Corporate Bond ETF, cutting an estimated $7.91M.
  • Blume Capital Management fully exited Lyft in Q2 2022, selling an estimated $384K.
  • Blume Capital Management's ten largest holdings make up 39% of its $253M portfolio in Q2 2022.
  • Blume Capital Management opened 30 new positions and closed 30 in Q2 2022.
  • Blume Capital Management's portfolio value fell 17% quarter-over-quarter to $253M.

Based on Blume Capital Management's 13F filing for Q2 2022, filed 11 Aug 2022.